Oxbow Advisors, LLC: PM position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Oxbow Advisors, LLC on PM, newest first. How the timeline and the estimate are built.
Oxbow Advisors, LLC held 1,346 PM shares at 2026-06-30 per its 13F-HR filed 2026-08-07.
the latest 13F is the newest step
- period ended2026-06-3013F 1,346 sharesChange vs previous 13F +36 shares
0.02% of the 13F portfolio, value $243,505.
13F-HR 0002085853-26-000957 filed by Oxbow Advisors, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 1,310 sharesChange vs previous 13F -345 shares
0.02% of the 13F portfolio, value $216,595.
13F-HR 0002085853-26-000513 filed by Oxbow Advisors, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 1,655 sharesChange vs previous 13F -42 shares
0.02% of the 13F portfolio, value $265,462.
13F-HR 0002085853-26-000196 filed by Oxbow Advisors, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 1,697 sharesChange vs previous 13F +40 shares
0.03% of the 13F portfolio, value $275,253.
13F-HR 0002085853-25-000209 filed by Oxbow Advisors, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 1,657 sharesChange vs previous 13F -654 shares
0.03% of the 13F portfolio, value $301,789.
13F-HR 0001667731-25-000996 filed by Oxbow Advisors, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 2,311 sharesChange vs previous 13F not available
0.04% of the 13F portfolio, value $366,825.
13F-HR 0001667731-25-000569 filed by Oxbow Advisors, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).